CRISPR/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogramming

By afschroeder • January 7, 2026

Wang MR, Mu W, Zhen A, Kitchen SG. CRISPR/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogramming. Trends Biotechnol. 2026 Jan 5:S0167-7799(25)00499-8. doi: 10.1016/j.tibtech.2025.12.001. Epub ahead of print. PMID: 41494892.

Tags: CAR-T, CRISPR/Cas, exhaustion, General Internal Medicine, Hematology/Oncology, Metabolism, persistence, Publications, Resident

Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right Atrial Rupture

Makaroff KE, Hampilos K, Sayed S, Emert B, Hu X, Nsair A, Kwon M, Middlekauff H. Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right[...]

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

Tian J, Azhir A, Decaro M, Chau N, Hügel J, Morris M, Cheng J, Fard P, Bassett IV, Bell DS, Bernstam EV, Visweswaran S, Klann[...]

Use of Evidence-Based Type 2 Diabetes Preventive Therapies and Rates of Progression to Diabetes Among Veterans with Prediabetes by Race and Ethnicity, 2010-2019

Ly DP, Washington DL, Shekelle PG, Lee ML, Moin T. Use of Evidence-Based Type 2 Diabetes Preventive Therapies and Rates of Progression to Diabetes Among[...]